King Pharmaceuticals Inc.
(NYSE:KG)|
10.44 -0.36 (-3.33%) Jan 07 - Close |
|
|
|
After-Hours 10.45 +0.01 (0.10%) Wed, 7 Jan 2009 7:40 PM
- Compare KG with:
- View: Line | Candlestick
Company Profile
King Pharmaceuticals Inc.
501 Fifth Street
Bristol, TN 37620
United States - Map
Phone: (423) 989-8000
Fax: (423) 989-8711
Website: www.kingpharm.com
State of incorporation: Tennessee
CEO: Brian A. Markison
Employees: 2,050
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
A drug-maker.
A pharmaceutical company that performs basic research and develops, manufactures, markets and sells branded prescription pharmaceutical products.
Recent news for KG
-
Final Glance: Pharmaceuticals companies
AP - 5 hours ago
-
Midday Glance: Pharmaceuticals companies
AP - 11 hours ago
-
Sun Rises In U.S. Generic Market
Forbes.com - 11 hours ago
-
Early Glance: Pharmaceuticals companies
AP - 13 hours ago
-
Final Glance: Pharmaceuticals companies
AP - Jan 06 at 5:51 ET
-
Midday Glance: Pharmaceuticals companies
AP - Jan 06 at 1:10 ET
-
Early Glance: Pharmaceuticals companies
AP - Jan 06 at 10:35 ET
-
Final Glance: Pharmaceuticals companies
AP - Jan 05 at 5:52 ET
-
EDGAR Online - Jan 05 at 5:19 ET
-
Endo Shifts Gears With Indevus
Forbes.com - Jan 05 at 4:30 ET
Member sentiment (?) Neutral
Top members owning KG
-
Top 96%
-3.53%
-
Top 35%
+2.76%
-
Top 41%
+2.12%
* Average monthly return vs. S&P 500
Recent opinions on KG
-
FDA Calendar: Allergan's New Rx for Eyelashes
Dec 27 2008 at 8:32 ET (By MikeHavRx)
-
FDA Calendar: High Hopes for Amgen's Bone Drug
Dec 25 2008 at 10:17 ET (By MikeHavRx)